Business Description
Shanxi Jinbo Bio pharmaceutical Co Ltd
ISIN : CNE100006392
Total Employee Number:
974Compare
Compare
Traded in other countries / regions
920982.China IPO Date
2023-07-20Description
Shanxi Jinbo Bio pharmaceutical Co Ltd is engaged in research & development, production and sales of various medical devices and functional skin care products with recombinant collagen products and anti-HPV biological protein products as the core.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.9 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 0.39 | |||||
Interest Coverage | 101.98 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 15.09 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 42.3 | |||||
3-Year EBITDA Growth Rate | 50.6 | |||||
3-Year EPS without NRI Growth Rate | 62.3 | |||||
3-Year FCF Growth Rate | 97.1 | |||||
3-Year Book Growth Rate | 48.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 20.47 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 21.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.53 | |||||
9-Day RSI | 52.4 | |||||
14-Day RSI | 49.22 | |||||
3-1 Month Momentum % | -27.42 | |||||
6-1 Month Momentum % | -42.66 | |||||
12-1 Month Momentum % | -60.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.09 | |||||
Quick Ratio | 3.67 | |||||
Cash Ratio | 2.8 | |||||
Days Inventory | 295.25 | |||||
Days Sales Outstanding | 57.23 | |||||
Days Payable | 195.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.16 | |||||
Dividend Payout Ratio | 0.45 | |||||
Forward Dividend Yield % | 1.16 | |||||
5-Year Yield-on-Cost % | 1.16 | |||||
3-Year Average Share Buyback Ratio | -9.5 | |||||
Shareholder Yield % | 1.24 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 87.98 | |||||
Operating Margin % | 47.99 | |||||
Net Margin % | 38.9 | |||||
EBITDA Margin % | 45.98 | |||||
FCF Margin % | 22.62 | |||||
OCF Margin % | 38.57 | |||||
ROE % | 33.78 | |||||
ROA % | 25.2 | |||||
ROIC % | 53.14 | |||||
3-Year ROIIC % | 78.95 | |||||
ROC (Joel Greenblatt) % | 87.78 | |||||
ROCE % | 35.24 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 23.83 | |||||
Forward PE Ratio | 18.45 | |||||
PE Ratio without NRI | 22.85 | |||||
Shiller PE Ratio | 48.56 | |||||
Price-to-Owner-Earnings | 28.91 | |||||
PEG Ratio | 0.38 | |||||
PS Ratio | 9.28 | |||||
PB Ratio | 7.33 | |||||
Price-to-Tangible-Book | 8.32 | |||||
Price-to-Free-Cash-Flow | 41.01 | |||||
Price-to-Operating-Cash-Flow | 24.03 | |||||
EV-to-EBIT | 17.55 | |||||
EV-to-EBITDA | 17.55 | |||||
EV-to-Revenue | 8.07 | |||||
EV-to-FCF | 35.68 | |||||
Price-to-GF-Value | 0.46 | |||||
Price-to-Projected-FCF | 4.45 | |||||
Price-to-DCF (Earnings Based) | 0.73 | |||||
Price-to-DCF (FCF Based) | 1.31 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.91 | |||||
Price-to-Graham-Number | 2.91 | |||||
| Price-to-Net-Current-Asset-Value | 15.62 | |||||
| Price-to-Net-Cash | 33.72 | |||||
Earnings Yield (Greenblatt) % | 5.7 | |||||
FCF Yield % | 2.42 | |||||
Forward Rate of Return (Yacktman) % | 21.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanxi Jinbo Bio pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,604.279 | ||
| EPS (TTM) (Â¥) | 5.43 | ||
| Beta | 0.9399 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 45.37 | ||
| 14-Day RSI | 49.22 | ||
| 14-Day ATR (Â¥) | 8.113403 | ||
| 20-Day SMA (Â¥) | 125.144 | ||
| 12-1 Month Momentum % | -60.09 | ||
| 52-Week Range (Â¥) | 112.05 - 345.53 | ||
| Shares Outstanding (Mil) | 115.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanxi Jinbo Bio pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanxi Jinbo Bio pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.500000 Cash Dividend | 2026-06-25 | 141.85 (-1.27%) | ||
| CNY 1.000000 Cash Dividend | 2025-09-25 | 296.30 (+3.46%) | ||
| CNY 1.538400 Cash Dividend | 2025-06-18 | 333.70 (-3.38%) | ||
| 1.3:1 Stock Split | 2025-06-18 | 333.70 (-3.38%) | ||
| CNY 0.769231 Cash Dividend | 2024-09-24 | 123.08 (-1.36%) |
Show
Entries
Shanxi Jinbo Bio pharmaceutical Co Ltd Frequently Asked Questions
What is Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:920982)'s stock price today?
The current price of BJSE:920982 is ¥129.49. The 52 week high of BJSE:920982 is ¥345.53 and 52 week low is ¥112.05.
When is next earnings date of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:920982)?
The next earnings date of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:920982) is .
Does Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:920982) pay dividends? If so, how much?
The Dividend Yield %  of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:920982) is 1.16% (As of Today), Highest Dividend Payout Ratio of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:920982) was 0.45. The lowest was 0.11. And the median was 0.24. The  Forward Dividend Yield % of Shanxi Jinbo Bio pharmaceutical Co Ltd(BJSE:920982) is 1.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shanxi Jinbo Bio pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers